Sonnet BioTherapeutics Holdings, Inc.
Climate Impact & Sustainability Data (2020-03)
Reporting Period: 2020-03
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- Recent business combination and related transactions (merger with Sonnet BioTherapeutics, Inc., acquisition of Atexakin Alfa development rights, spin-off of restaurant business), requiring significant resources for closing transactions, post-closing transition activities, and preparation of unaudited interim reviewed financials. Change in management team also added to the complexity.
Mitigation Strategies
- Filing the Form 10-Q within the five-calendar-day extension period provided by Rule 12b-25.